Menu
1-702-720-6310 info@microcapspecualtors.com

Biotech Movers: Novavax Falls Again After New Data on RSV Vaccine Fails to Excite – TheStreet.com


TheStreet.com

Biotech Movers: Novavax Falls Again After New Data on RSV Vaccine Fails to Excite
TheStreet.com
Shares of vaccine company Novavax Inc. (NVAX) were down 24% to $1.15 early Tuesday afternoon. The Gaithersburg, Md.-based firm after the market close on Monday reported positive topline data from its Phase 2 safety and immunogenicity trial of the RSV ...
Novavax, Inc. - NVAX - Stock Price Today - ZacksZacks Investment Research

all 102 news articles »

Read More

Boosts in R&D Spending Drive Biotech Innovation, BDO USA Analysis Finds – CPAPracticeAdvisor.com


Zacks.com

Boosts in R&D Spending Drive Biotech Innovation, BDO USA Analysis Finds
CPAPracticeAdvisor.com
Fueled by a desire for innovation and new medical breakthroughs, the biotech industry continues to enjoy substantial growth due to increased investment in research and development (R&D), according to the sixth annual study from BDO USA, LLP. The 2017 ...
Biotech ETF Industry Outlook for Second Half 2017Zacks.com

all 2 news articles »

Read More

Could This Small Biotech Break Out On A Tie-Up With Eli Lilly? – Investor’s Business Daily


Investor's Business Daily

Could This Small Biotech Break Out On A Tie-Up With Eli Lilly?
Investor's Business Daily
Nektar Therapeutics (NKTR) stock neared a breakout Monday after announcing a deal with Eli Lilly (LLY) to develop an drug that could stoke the immune system to fight autoimmune and inflammatory conditions. XAutoplay: On | OffIn morning trading on the ...
Biotech Movers: NeuroDerm Shares Soar on Sale to Japanese FirmTheStreet.com

all 120 news articles »

Read More
Search